These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
24. Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. Shukla S; Patric IR; Patil V; Shwetha SD; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Somasundaram K J Biol Chem; 2014 Aug; 289(32):22306-18. PubMed ID: 24923441 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma. Lambertz N; El Hindy N; Kreitschmann-Andermahr I; Stein KP; Dammann P; Oezkan N; Mueller O; Sure U; Zhu Y BMC Cancer; 2015 Oct; 15():759. PubMed ID: 26490252 [TBL] [Abstract][Full Text] [Related]
26. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257 [TBL] [Abstract][Full Text] [Related]
27. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952 [TBL] [Abstract][Full Text] [Related]
28. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
29. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling. Li Q; Wang J; Ma X; Wang M; Zhou L J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584 [TBL] [Abstract][Full Text] [Related]
30. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942 [TBL] [Abstract][Full Text] [Related]
31. Reprogramming Glioblastoma Cells into Non-Cancerous Neuronal Cells as a Novel Anti-Cancer Strategy. Jiang MQ; Yu SP; Estaba T; Choi E; Berglund K; Gu X; Wei L Cells; 2024 May; 13(11):. PubMed ID: 38891029 [TBL] [Abstract][Full Text] [Related]
32. The DNA methylome of glioblastoma multiforme. Martinez R; Esteller M Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612 [TBL] [Abstract][Full Text] [Related]
34. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883 [TBL] [Abstract][Full Text] [Related]
36. Modulation of miR-21 signaling by MPS1 in human glioblastoma. Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
38. Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma. Brigliadori G; Foca F; Dall'Agata M; Rengucci C; Melegari E; Cerasoli S; Amadori D; Calistri D; Faedi M J Neurooncol; 2016 Jun; 128(2):333-9. PubMed ID: 27029617 [TBL] [Abstract][Full Text] [Related]
39. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas. Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304 [TBL] [Abstract][Full Text] [Related]
40. FOXO4 expression associates with glioblastoma development and FOXO4 expression inhibits cell malignant phenotypes in vitro and in vivo. Qi M; Sun LA; Jiang XC; Han YL; Wang L; Niu WH; Fei MX; Zhaba WD; Zheng LR; Zhou ML Life Sci; 2020 Apr; 247():117436. PubMed ID: 32070707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]